4th ADC Linker and conjugation summit

The 4th ADC Linker & Conjugation Summit 2026 will take place from 28–30 July 2026 in Boston, Massachusetts, USA, bringing together specialists working at the forefront of antibody-drug conjugate (ADC) chemistry. Designed as a highly technical and focused meeting, the summit provides a dedicated platform for discovery chemists, protein engineers and translational scientists to address the challenges associated with linker design, conjugation technologies and next-generation ADC development.

The event focuses on advancing linker architecture and conjugation chemistry to improve ADC stability, reduce off-target toxicity, overcome tumour resistance and maintain manufacturability. As ADC innovation expands into dual-payload constructs, high-DAR species, degrader-antibody conjugates and other emerging modalities, the summit aims to provide practical solutions for developing safer, more effective and clinically translatable therapies.

Attendees will join 80+ discovery chemists, protein engineers and translational leaders for three days of technical discussions, collaborative networking, workshops and case-study-driven learning. The programme includes 20+ expert-led case studies, interactive workshops and technical debates covering site-specific conjugation, enzymatic and glycan-directed strategies, orthogonal conjugation systems, dual-payload ADCs, computational modelling, linker stability optimisation and pharmacokinetic enhancement.

The